- ISIN
- US9286611077
- CUSIP
- 928661107
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- IPO Date
- Apr 25, 2007
Highlights
- Market Cap
- $5.99M
- Enterprise Value
- $7.86M
- EPS (TTM)
- -$0.21
- Total Revenue (TTM)
- $1.47M
- Gross Profit (TTM)
- $1.47M
- EBITDA (TTM)
- -$20.26M
- Year Range
- $0.69 - $15.10
- ROA (TTM)
- -331.53%
- ROE (TTM)
- 64.28%
- Avg. Volume (1M)
- 268K
- Avg. Volume Value (1M)
- $284.50K
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
VNRX Performance Chart
VolitionRx Limited (VNRX) is down 86.0% since the beginning of the year. At $1 per share, VNRX is trading 95.2% below its 52-week high of $15. Investors who bought $1,000 worth of VNRX shares 5 years ago would now be looking at an investment worth $11.
Loading charts...
Compare this symbol against anything
Returns By Period
VolitionRx Limited (VNRX) has returned -85.95% so far this year and -94.39% over the past 12 months. Over the last ten years, VNRX has returned -36.62% per year, falling short of the S&P 500 Index benchmark, which averaged 13.26% annually.
VolitionRx Limited
- 1D
- -10.20%
- 1M
- -48.71%
- 6M
- -87.40%
- YTD
- -85.95%
- 1Y
- -94.39%
- 3Y*
- -70.30%
- 5Y*
- -59.21%
- 10Y*
- -36.62%
- ALL TIME*
- -24.92%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
VNRX Monthly Returns History
Based on dividend-adjusted daily data since Oct 11, 2011, VNRX's average daily return is +0.02%, while the average monthly return is -0.59%.
Historically, 42% of months were positive and 58% were negative. The best month was Sep 2014 with a return of +109.4%, while the worst month was Jun 2026 at -49.4%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 8 months.
On a daily basis, VNRX closed higher 40% of trading days. The best single day was Oct 26, 2011 with a return of +50.0%, while the worst single day was Sep 22, 2023 at -32.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 11.50% | -25.26% | -5.16% | -35.15% | 1.91% | -49.44% | -46.81% | -85.95% | |||||
| 2025 | -0.83% | 4.20% | -8.05% | -15.80% | 4.79% | 51.09% | -15.63% | 7.61% | -1.62% | -36.06% | -25.88% | -20.55% | -57.40% |
| 2024 | 47.84% | -7.55% | -22.76% | 18.88% | -21.58% | -14.27% | 9.42% | 8.76% | -16.53% | -8.49% | 25.45% | -13.04% | -16.32% |
| 2023 | 1.65% | -19.03% | -4.50% | -10.99% | -8.82% | -10.32% | -3.60% | -6.72% | -44.88% | 12.18% | -1.93% | -5.41% | -70.49% |
| 2022 | -15.61% | 10.19% | 3.08% | -7.31% | -7.17% | -20.85% | -0.98% | -16.75% | -19.53% | 46.32% | 19.60% | 2.10% | -22.61% |
| 2021 | 18.51% | -11.50% | -7.35% | -11.38% | 4.18% | -5.73% | -3.34% | 3.77% | -6.06% | 7.42% | -3.00% | -2.79% | -19.28% |
Benchmark Metrics
VolitionRx Limited has an annualized alpha of -5.83%, beta of 0.75, and R2 of 0.02 versus S&P 500 Index. Calculated based on daily prices since October 11, 2011.
- This stock participated in 157.70% of S&P 500 Index downside but only -12.82% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.02 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -5.83%
- Beta
- 0.75
- R²
- 0.02
- Upside Capture
- -12.82%
- Downside Capture
- 157.70%
Return for Risk
Risk / Return Rank
VNRX ranks 3 for risk / return — above 3% of stocks peers on PortfoliosLab. Its historical combined result is below most peers; review the five component ranks for context.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for VolitionRx Limited (VNRX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VNRX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.44 | ||
| Sortino ratioReturn per unit of downside risk | -5.49 | ||
| Omega ratioGain probability vs. loss probability | 0.63 | 1.25 | -0.62 |
| Calmar ratioReturn relative to maximum drawdown | -1.00 | 2.00 | -3.00 |
| Martin ratioReturn relative to average drawdown | -1.48 | 8.49 | -9.97 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the VolitionRx Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the VolitionRx Limited was 99.45%, occurring on Jul 31, 2026. The portfolio has not yet recovered.
The current VolitionRx Limited drawdown is 99.45%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-99.45%Jul 2026 | 5y 5mo | — | 5y 5moFeb 2021 - now | — |
-72.16%Aug 2018 | 1y 10mo | 1y 1mo | 2y 12moSep 2016 - Sep 2019 | — |
-69.84%Nov 2013 | 1y 25d | 10mo 14d | 1y 11moOct 2012 - Sep 2014 | — |
-61.53%Mar 2020 | 5mo 22d | 10mo 29d | 1y 4moSep 2019 - Feb 2021 | COVID crash2020 |
-42.75%May 2015 | 3mo 23d | 4mo 12d | 8mo 5dJan 2015 - Sep 2015 | — |
Drawdown Indicators
| VNRX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.45% | -56.78% | -42.67% |
Max Drawdown (1Y)Largest decline over 1 year | -94.83% | -9.10% | -85.73% |
Max Drawdown (3Y)Largest decline over 3 years | -97.32% | -18.90% | -78.42% |
Max Drawdown (5Y)Largest decline over 5 years | -99.13% | -25.43% | -73.70% |
Max Drawdown (10Y)Largest decline over 10 years | -99.45% | -33.92% | -65.53% |
Current DrawdownCurrent decline from peak | -99.45% | -1.58% | -97.87% |
Average DrawdownAverage peak-to-trough decline | -50.39% | -10.70% | -39.69% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 63.85% | 2.14% | +61.71% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of VolitionRx Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how VolitionRx Limited is priced in the market compared to other companies in the Diagnostics & Research industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for VNRX relative to other companies in the Diagnostics & Research industry. Currently, VNRX has a P/S ratio of 52.8. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with VNRX
Add VolitionRx Limited to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with VNRX